Myos Rens Technology Inc. (NASDAQ:MYOS)

MYOS Corporation, a development stage company, focuses on the discovery, development, and commercialization of therapeutic products, nutritional supplements, and other technologies for improving the health and performance of muscle tissue. It develops MYO-T12, an over-the-counter supplement that is a myostatin inhibitor to optimize biological activity. The company was formerly known as Atlas Therapeutics Corporation and changed its name to MYOS Corporation in May 2012. MYOS Corporation was founded in 2007 and is based in Cedar Knolls, New Jersey.

Web site: http://www.myoscorp.com

Last updated June 13, 2012